Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141269 · ClinicalTrials.gov registry record
Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT02141269 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 200 participants.
The verdict
NCT02141269 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
A new hand held pocket echo device (GE Vscan) has now become available to clinicians, with limited data available comparing the effectiveness of this device as a screening tool when compared to traditional transthoracic echocardiography (TTE). The investigators are evaluating the effectiveness of this hand-held echo (HHE) device in detecting cardiac pathology in a both an inpatient and outpatient clinical setting as compared to a comprehensive TTE evaluation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02141269
The ClinicalTrials.gov registry entry for NCT02141269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02141269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02141269 about?
NCT02141269 is a clinical study titled "Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)". A new hand held pocket echo device (GE Vscan) has now become available to clinicians, with limited data available comparing the effectiveness of this device as a screening tool when compared to traditional transthoracic echocardiography (TTE). The investigators are evaluating the effectiveness of t...
What is the current status of trial NCT02141269?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-06. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT02141269?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.